Recent News

• 02.18.2025 - Erez Kalir
• 02.18.2025 - Erez Kalir
• 02.13.2025 - Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials
• 02.13.2025 - Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials
• 02.12.2025 - Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
• 02.12.2025 - Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
• 02.03.2025 - Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
• 02.03.2025 - Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Recent Filings

• 02.13.2025 - 144 Report of proposed sale of securities
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.10.2025 - 144 Report of proposed sale of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 8-K Current report
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities